Works by Ku, J


Results: 121
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.

    Published in:
    Diabetes, Obesity & Metabolism, 2015, v. 17, n. 6, p. 599, doi. 10.1111/dom.12435
    By:
    • Jin, S.‐M.;
    • Park, C.‐Y.;
    • Cho, Y. M.;
    • Ku, B. J.;
    • Ahn, C. W.;
    • Cha, B.‐S.;
    • Min, K. W.;
    • Sung, Y. A.;
    • Baik, S. H.;
    • Lee, K. W.;
    • Yoon, K.‐H.;
    • Lee, M.‐K.;
    • Park, S. W.
    Publication type:
    Article
    18

    Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 309, doi. 10.1111/dom.12424
    By:
    • Kim, M. K.;
    • Rhee, E.‐J.;
    • Han, K. A.;
    • Woo, A. C.;
    • Lee, M.‐K.;
    • Ku, B. J.;
    • Chung, C. H.;
    • Kim, K.‐A.;
    • Lee, H. W.;
    • Park, I. B.;
    • Park, J. Y.;
    • Chul Jang, H. C.;
    • Park, K. S.;
    • Jang, W. I.;
    • Cha, B. Y.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50